Skip to main content

Olema Pharmaceuticals, Inc.

OLMA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001750284

In the last 90 days, Olema Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 1 sale; 185 institutions reported holding it in 13F filings for Q2 2026, worth $1.28B in total; Duquesne Family Office is the only superinvestor holding it.

Q4 2022 vs. Q3 2022

How the institutions holding Olema Pharmaceuticals, Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of OLMA: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders7367−6
Shares33.4M33.3M−26.2K (−0.1%)
Value$92.1M$81.6M−$10.4M (−11.3%)

New holders (7)

Institutions that held Olema Pharmaceuticals, Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to OLMA in Q4 2022
InstitutionSharesValue% of portfolio
Vontobel Holding Ltd.526,813$1.29M0.01%
J. Goldman & Co LP515,577$1.26M0.09%
Anson Funds Management LP129,631$317.6K0.10%
Ergoteles LLC38,906$95.3K0.00%
Walleye Capital LLC31,301$76.7K0.00%
Virtu Financial LLC13,515$33.0K0.00%
Jane Street Group, LLC11,406$27.9K0.00%

Sold out (13)

Institutions that held Olema Pharmaceuticals, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.